Created at Source Raw Value Validated value
Nov. 26, 2021, 10:30 p.m. oms

1. Moderate to high risk of exposure to infected patients during the study period. <br/ >2. Healthy at the time of enrolment without any symptoms suggestive of any viral infection.

1. Moderate to high risk of exposure to infected patients during the study period. <br/ >2. Healthy at the time of enrolment without any symptoms suggestive of any viral infection.

Nov. 13, 2021, 5:33 p.m. oms

Oct. 26, 2020, 8:29 a.m. oms

1. Moderate to high risk of exposure to infected patients during the study period. <br/ >2. Healthy at the time of enrolment without any symptoms suggestive of any viral infection.

1. Moderate to high risk of exposure to infected patients during the study period. <br/ >2. Healthy at the time of enrolment without any symptoms suggestive of any viral infection.